Press releases

Month Year

Email alerts

Feb 8, 2011

Medtronic Receives FDA Approval for First and Only Pacemaker System in the U.S. Designed for Use in the MRI Environment

Revo MRI(TM) SureScan(R) Pacing System Offers Pacemaker Patients Access to MRI Scans

MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI(TM) SureScan(R) pacing system, the...
Feb 8, 2011

Medtronic Issues Statement on District Court Ruling Regarding CoreValve

MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. District Court of Delaware issued its ruling on post-trial motions filed by the parties in...
Feb 4, 2011

Medtronic: Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients

Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS

MINNEAPOLIS, Feb 04, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
Jan 27, 2011

Medtronic Announces Global Launch of the CD HORIZON(R) SOLERA(TM) Spinal System

Latest innovation in technology offers new capabilities for surgeons, hospitals and their patients

MEMPHIS, Tenn., Jan 27, 2011 (BUSINESS WIRE) -- Continuing a stream of recent advancements for stabilization of the spine, Medtronic, Inc. (NYSE: MDT) today announced both the release of its CD...
Jan 18, 2011

Medtronic Revises Design ofCoreValve(R) U.S. Pivotal Trial

Inoperable Patients Will Be Evaluated in Single Arm Study, Not Randomized to Medical Management

MINNEAPOLIS, Jan 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to modify its...

Show per page